Orchestra BioMed is a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine. The company partners with established market leaders to drive global commercialization of its products, establishing multiple long-term potential revenue streams and supporting further product development. Its current product pipeline was organically developed and features Virtue® Sirolimus-Eluting Balloon (SEB) for the treatment of artery disease, the leading cause of death worldwide, and BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension, the leading contributing risk factor for death worldwide. Orchestra BioMed’s business model optimizes capital efficiency and cash flow by developing therapies with a high probability of success that fulfill a specific need, fit within current clinical workflow and deliver health-economic value. Orchestra BioMed is led by a multi-disciplinary team with a long track record of successful product development.
Location: United States, New York, Town of Niles
Employees: 11-50
Total raised: $34M
Founded date: 2017
Founders name: David Hochman
Founders Related Locations: United States, Pennsylvania, New Hope; Ireland, Galway City; United States, New York, Town of Niles; United States, New York, New York
Investors 1
| Date | Name | Website |
| - | Perceptive... | perceptive... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.07.2019 | Series B | $34M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | David | Hochman | Chairman, ... | linkedin.c... | - | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 13.03.2024 | Orchestra BioMed Demonstrates Strength of Cardiovascular Pip... | - | globenewsw... |
| 07.03.2024 | Orchestra BioMed to Participate in Upcoming Investor Confere... | - | globenewsw... |
| 06.03.2024 | Orchestra BioMed Announces Presentation of Results from Clin... | - | globenewsw... |
| 10.12.2019 | Orchestra BioMed Secures $20 Million Financing Facility from... | NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc., a biomedical innovation company ... | citybizlis... |
| 15.07.2019 | Orchestra BioMed Inks $34M Series B-1 Financing | NEW HOPE, PA, Biomedical innovation company announced it has completed a $34 million Series B-1 fi... | vcnewsdail... |
| 15.07.2019 | Orchestra BioMed Raises $34M | NEW HOPE, Pa., July 10, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc., a biomedical innovation com... | citybizlis... |
| 12.07.2019 | Encore: Orchestra BioMed quickly nets another $34M for its c... | Hot on the heels of inking an international distribution deal with Terumo, Orchestra BioMed has secu... | fiercebiot... |
| 12.07.2019 | Encore: Orchestra BioMed quickly nets another $34M for its c... | Hot on the heels of inking an international distribution deal with Terumo, Orchestra BioMed has secu... | fiercebiot... |
| 19.11.2018 | Orchestra BioMed Completed $41M Equity Financing | Orchestra BioMed, Inc., a New Hope, PA-based biomedical innovation company developing advanced thera... | finsmes.co... |